$TDOC

Vandervoort Adam C sold $60K of TDOC

Vandervoort Adam C (CHIEF LEGAL OFFICER, SECRETARY) sold 7,906 shares of Teladoc Health, Inc. (TDOC) at $7.63 on 2026-06-02.

Original reporting
SEC EDGAR · Vandervoort Adam C
Published Jun 3, 2026, 8:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

Traders may monitor for clustering of insider sales or subsequent disclosures, but this specific filing does not introduce new operational or financial information.

02

Market read

A disclosed insider sale can slightly influence sentiment, but without any accompanying corporate event, expected market impact is limited.

03

What to watch

No 10b5-1 plan is stated, but the filing alone doesn’t reveal reasons (taxes, diversification, personal liquidity) or whether other insiders are selling/buying concurrently.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed June 3 (sale executed June 2)

Background

SEC Form 4 reports insider transactions by company officers/directors/10% owners; these filings are public but often not tied to new company fundamentals.

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

Teladoc Health insider Form 4 shows Chief Legal Officer sold 7,906 shares in an open-market transaction on June 2.

Expected impact

Low near-term impact; any reaction is likely sentiment-driven and short-lived.

Evidence & confidence

This is a routine SEC Form 4 insider transaction with no 10b5-1 plan and no accompanying company-specific event (earnings, guidance, deal, litigation).

Market effects

Minimal; single insider sale in a telehealth/healthcare IT name typically does not reset sector expectations.

None.

None.

Counterpoint

The sale may be routine liquidity/compensation-related rather than a bearish signal, especially given the modest dollar value versus typical institutional flows.

Key entities

  • Teladoc Health, Inc.

    TDOC insider transaction disclosure: Chief Legal Officer sold 7,906 shares at $7.6270 on June 2; Form 4 filed June 3.

Related articles

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky said it is investigating Teladoc Health (NYSE: TDOC) after the company reported Q2 2026 revenue of $606.9 million, below consensus of $615 million to $628 million, and cut full-year 2026 revenue guidance to $2.36 billion to $2.45 billion. The notice cites prior guidance changes and comments about BetterHelp cash pay user declines and insurance capacity.

$METAMed

Futures Rise As Oil Drops, Bond Selling Slows, Meta Tumbles And Microsoft Soars

US stock index futures rose in premarket after a prior selloff tied to Fed-related concerns. Microsoft shares jumped about 9% after cloud growth accelerated, while Meta fell about 8% after revenue guidance disappointed and free cash flow was weak. Bond selling slowed and 30-year yields hit a two-decade high near 5.22%. Several other earnings moves were reported, including MO, CVNA, CMG, and QCOM.